Skip to main content

Table 4 Association between established type 2 diabetes (T2D) loci in latent autoimmune diabetes in adulthood (LADA) cases positive for glutamic acid decarboxylase autoantibodies (GADA) and insulinoma-associated antigen-2 autoantibodies (IA2A). T2D variants that were significantly associated in LADA cases positive for GAD and IA2 autoantibodies (n = 309) (LADA association P value) are shown, as well as signals that were significantly different between LADA and T2D cases (LADA vs. T2D P value). The significance threshold was set to P < 7.04 × 10–4 to correct for multiple testing. The locus reported is the closest, well-known gene of interest to the signal (a full list of genes is provided in Additional file 1: Table S5). T2D risk allele frequencies reported are derived from the Bone Mineral Density in Childhood Study control data set (n = 1057), the Wellcome Trust Case Control Consortium T2D (n = 1960), and the LADA cases positive for autoantibodies GADA and IA2A (n = 309). The odds ratios for LADA are shown both GEMMA-corrected (for relatedness and batch effects) and uncorrected

From: Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes

Locus

SNP

T2D alleles risk/other

Risk allele frequency

LADA odds ratio

LADA P value

LADA vs. T2D P value

LADA

T2D

Control

HNF1A

rs12427353

G/C

0.857

0.828

0.787

1.474 (1.438–1.511)

2.52 × 10–4

5.42 × 10–2

ZBED3

rs6878122

A/G

0.744

0.658

0.706

1.216 (1.184–1.249)

3.86 × 10–2

1.47 × 10–5

TCF7L2

rs7903146

T/C

0.251

0.376

0.298

0.852 (0.820–0.883)

8.14 × 10–2

2.56 × 10–7